We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GLTO market cap is 19.11M. The company's latest EPS is USD -1.4144 and P/E is -0.49.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.62M | -13.53M | -13.49M | -11.16M | -8.58M |
| Net Income | -13.73M | -14.07M | -12.99M | -10.74M | -8.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -38.97M | -33.64M | -52.23M | -61.21M | -39.91M |
| Net Income | -42.07M | -34.84M | -51.75M | -61.62M | -38.35M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 82.03M | 73.19M | 64.63M | 58.8M | 50.05M |
| Total Liabilities | 9.3M | 11.44M | 14.3M | 15.1M | 12.67M |
| Total Equity | 72.73M | 61.75M | 50.33M | 43.7M | 37.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 56.61M | 171.6M | 122.22M | 73.19M | 38.23M |
| Total Liabilities | 8.14M | 6.11M | 4.99M | 11.44M | 5.9M |
| Total Equity | -71.15M | 165.49M | 117.22M | 61.75M | 32.33M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31.48M | -42.93M | -9.13M | -16.98M | -25.44M |
| Investing | -1.95M | 12.38M | 1.37M | 4.47M | 12.75M |
| Financing | 442k | 507k | 23k | 2.71M | 2.88M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.33M | -38.2M | -52.31M | -42.93M | -36.91M |
| Investing | -326k | N/A | -48.05M | 12.38M | 22.33M |
| Financing | N/A | 187.39M | N/A | 507k | 2.88M |
| Market Cap | 19.11M |
| Price to Earnings Ratio | -0.49 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.88 |
| Price to Book Ratio | 0.59 |
| Dividend Yield | - |
| Shares Outstanding | 27.11M |
| Average Volume (1 week) | 69.4k |
| Average Volume (1 Month) | 126.03k |
| 52 Week Change | -62.91% |
| 52 Week High | 3.70 |
| 52 Week Low | 0.50 |
| Spread (Intraday) | 0.03 (3.81%) |
| Company Name | Galecto Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.galecto.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
